Topic: Hiv Prevention

The FDA has approved Lenacapavir, a twice-yearly injection that is reportedly over 99.9% effective at preventing HIV. Manufacturer Gilead Sciences set the list price at approximately $28,000 per year. While medical professionals hail it as a breakthrough for those who struggle with daily pill compliance, critics question the high cost and the reliance on federal funding for access.

An investigation into the aggressive marketing of the drug Truvada (PrEP) for HIV prevention, particularly within the porn industry and on apps like Grindr. The segment criticizes NPR and Kaiser Permanente for "native advertising" that downplays the continued need for condoms, noting the emergence of the controversial term "Truvada Whore."

A new study reported by NPR suggests that taking a daily antiviral pill can significantly reduce the transmission of HIV between partners. The World Health Organization is expected to issue new recommendations this summer regarding the use of these drugs for prevention. Medical experts emphasize that this treatment requires a lifelong commitment to daily medication to remain effective.